New chemical and genetic approaches to vaccination: prevention of AIDS and other viral, bacterial, and parasitic diseases
Saved in:
| Format: | Book |
|---|---|
| Language: | Undetermined |
| Published: |
Cold Spring Harbor
Cold Spring Harbor Laboratory
1988
|
| Series: | Vaccines
1988 |
| Subjects: | |
| Online Access: | Inhaltsverzeichnis |
| Physical Description: | XXII, 396 S. Ill. |
| ISBN: | 087969310X |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV000826658 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 881024s1988 a||| |||| 10||| und d | ||
| 020 | |a 087969310X |9 0-87969-310-X | ||
| 035 | |a (OCoLC)230931936 | ||
| 035 | |a (DE-599)BVBBV000826658 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | |a und | ||
| 049 | |a DE-12 | ||
| 245 | 1 | 0 | |a New chemical and genetic approaches to vaccination |b prevention of AIDS and other viral, bacterial, and parasitic diseases |c ed. by Harold Ginsberg ... |
| 264 | 1 | |a Cold Spring Harbor |b Cold Spring Harbor Laboratory |c 1988 | |
| 300 | |a XXII, 396 S. |b Ill. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Vaccines |v 1988 | |
| 650 | 0 | 7 | |a Aids |0 (DE-588)4112470-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Impfung |0 (DE-588)4026656-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Impfstoff |0 (DE-588)4026655-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Virusimpfstoff |0 (DE-588)4257636-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1987 |z Cold Spring Harbor NY |2 gnd-content | |
| 689 | 0 | 0 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Impfung |0 (DE-588)4026656-4 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Virusimpfstoff |0 (DE-588)4257636-2 |D s |
| 689 | 2 | 1 | |a Aids |0 (DE-588)4112470-4 |D s |
| 689 | 2 | |5 DE-604 | |
| 700 | 1 | |a Ginsberg, Harold |e Sonstige |4 oth | |
| 830 | 0 | |a Vaccines |v 1988 |w (DE-604)BV000345041 |9 1988 | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000518934&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-000518934 | ||
Record in the Search Index
| _version_ | 1804115280275701760 |
|---|---|
| adam_text | VACCINESBB NEW CHEMICAL AND GENETIC APPROACHES TO VACCINATION:
PREVENTION OF AIDS AND OTHER VIRAL, BACTERIAL, AND PARASITIC DISEASES
EDITED BY HAROLD GINSBERG COLUMBIA UNIVERSITY COLLEGE OF PHYSICIANS &
SURGEONS FRED BROWN WELLCOME BIOTECHNOLOGY LTD. RICHARD A. LERNER
RESEARCH INSTITUTE OF SCRIPPS CLINIC ROBERT M. CHANOCK NATIONAL
INSTITUTES OF HEALTH COLD SPRING HARBOR LABORATORY 1988 CONTENTS
CONFERENCE PARTICIPANTS, V PREFACE, XV SECTION I IMMUNOLOGY PEPTIDES
WITH ADDED T-CELL EPITOPES CAN OVERCOME GENETIC RESTRICTION OF THE
IMMUNE RESPONSE 1 MICHAEL J. FRANCIS, GILLIAN Z. HASTINGS, ANDREW D.
SYRED, BRIAN MCGINN, FRED BROWN, AND DAVID J. ROWLANDS USE OF MULTIPLE
PEPTIDE ANALOGS AS PROBES IN THE DETAILED STUDY OF ANTIBODY-ANTIGEN
INTERACTIONS 9 RICHARD A. HOUGHTEN, JON APPEL, AND CLEMENCIA PINILLA
MULTIVALENT HEPATITIS-B SYNTHETIC VACCINE 13 DAVID R. MILICH, ALAN
MCLACHLAN, JANICE L. HUGHES, ANN MORIARTY, AND GEORGE B. THORNTON
INDUCTION OF ANTITUMOR IMMUNITY BY IMMUNIZATION WITH A VACCINIA VIRUS
VECTOR EXPRESSING AN ONCOGENE-ENCODED PRODUCT 19 SARA J. MCKENZIE,
ANTOINETTE DESTREE, ETHEL GORDON, DENNIS PANICALI, RENE BERNARDS, AND
ROBERT WEINBERG STRUCTURE OF THE NEUTRALIZATION EPITOPE OF THE REOVIRUS
TYPE-3 HEMAGGLUTININ 25 WILLIAM WILLIAMS, H. ROBERT GUY, DAVID WEINER,
DONALD RUBIN, AND MARK I. GREENE A FUNCTIONAL RECOMBINANT IMMUNOGLOBULIN
VARIABLE DOMAIN FROM POLYPEPTIDES PRODUCED IN ESCHERICHIA COLI 29 HELEN
FIELD, ANTHONY R. REES, AND GEOFFERY T. YARRANTON USE OF PEPTIDES TO
LOCATE AND CHARACTERIZE EPITOPES 35 ROB H. MELOEN, WOUTER C. PUYK,
WILLEM PA. POST HUMUS, HANNEKE LANKHOF, ADRI THOMAS, AND WIM M.M.
SCHAAPER CYTOLYTIC T LYMPHOCYTES INDUCED BY A VACCINIA RECOMBINANT
EXPRESSING A HERPESVIRUS NONSTRUCTURAL IMMEDIATE-EARLY PROTEIN PROTECT
AGAINST CYTOMEGALOVIRUS INFECTION 41 ULRICH KOSZINOWSKI, HANSJURGEN
VOLKMER, MARTIN MESSERLE, STIPAN JONJIC, AND RICCARDO WITTEK RECOMBINANT
VACCINIA VIRUS EXPRESSING THE HUMAN MELANOMA-ASSOCIATED ANTIGEN P97 AS A
THERAPEUTIC ANTI-TUMOR VACCINE 47 SHIU-LOK HU, CHARLES D. ESTIN, ULRIKE
S. STEVENSON, GREGORY D. PLOWMAN, INGEGERD HELLSTROM, AND KARL-ERIK
HELLSTROM XVII XVIII CONTENTS SECTION II PARASITOLOGY SYNTHETIC VACCINES
IN SCHISTOSOMIASIS: GLYCAN AND PROTEIN PROTECTIVE EPITOPES 53 JEAN-MARC
BALLOUL, JEAN-MARIE GRZYCH, COLLETTE DISSOUS, DENIS BOULANGER, JOSETTE
FONTAINE, ANDRE CAPRON, PAUL SONDERMEYER, MARIE PAULE KIENY, ANNICK
VIDAL, AND JEAN-PIERRE LECOCQ AN APPROACH FOR IDENTIFYING PROTECTIVE
LEISHMANIAL ANTIGENS BY T-CELL CLONING AND IMMUNOBLOTTING 57 PHILLIP
SCOTT, EDWARD PEARCE, PATRICIA NATOVITZ, AND ALAN SHER SYNTHETIC PEPTIDE
VACCINE AGAINST MURINE MALARIA 61 FIDEL ZAVALA, PEDRO J. ROMERO,
VICTORIA LEY, RUTH S. NUSSENZWEIG, VICTOR NUSSENZWEIG, JAMES P. TARN,
AND PHILIP J. BARR ANTIBODIES AGAINST THE REPEAT REGION OF
CIRCUMSPOROZOITE PROTEIN ARE NOT PROTECTIVE AGAINST CHALLENGE BY
SPOROZOITE: A RODENT MODEL STUDY 67 ALTAI A. LAI, VIDAL F. DE LA CRUZ,
MICHAEL F. GOOD, W. LEE MALOY, JUDITH A. WELSH, MILFORD LUNDE, THOMAS F.
MCCUTCHAN, AND WALTER R. WEISS IMMUNITY TO MALARIA SPOROZOITES REQUIRES
CD8 + (SUPRESSOR/CYTOTOXIC) T CELLS AND Y-LNTERFERON 71 LOUIS SCHOFIELD,
RUTH NUSSENZWEIG, AND VICTOR NUSSENZWEIG T-CELL EPITOPES OF THE MALARIA
CIRCUMSPOROZOITE PROTEIN MAP TO POLYMORPHIC SEGMENTS OF THE MOLECULE 79
MICHAEL F. GOOD, W. LEE MALOY, DAVID POMBO, ISABELLA A. QUAKYI, MILFORD
N. LUNDE, DAVID W. AILING, VIDAL F. DE LA CRUZ, JAY A. BERZOFSKY, LOUIS
H. MILLER, WALTER R. WEISS, ELEANOR M. RILEY, ARUN MENON, AND RICHARD A.
HOUGHTEN ADOPTIVE PROTECTION IN NUDE MICE AGAINST A MURINE MALARIAL
PARASITE USING A CLONED T-CELL LINE 85 DAVID A. BRAKE, JAMES M. BURNS,
JR., WILLIAM P. WEIDANZ, AKHIL B. VAIDYA, AND CAROLE A. LONG
COCKTAIL VACCINES AGAINST FALCIPARUM MALARIA 89 CHRIS LANGFORD, DONALD
SMITH, LISA KEAM, LYNN CORCORAN, GREG PETERSON, PETER MCLNTYRE, DAVID
KEMP, ROBIN ANDERS, STIRLING EDWARDS, AND DAVID PYE SECTION III BACTERIA
AND BACTERIAL DISEASES MULTIVALENT SYNTHETIC VACCINES AGAINST GROUP-A
STREPTOCOCCI 95 EDWIN H. BEACHEY AND JAMES B. DALE BIOCHEMICAL AND
IMMUNOLOGICAL ANALYSES OF PERTUSSIS TOXIN SUBUNITS PRODUCED IN
RECOMBINANT ESCHERICHIA COLI 99 JERRY M. KEITH, WITOLD CIEPLAK, KAAREL
T. KALJOT, KEVIN S. MARCHITTO, HIROKO SATO, VERNON L. MAR, AND W. NEAL
BURNETTE HUMORAL RESPONSE TO SYNTHETIC PEPTIDES REPRESENTING THE AMINO
TERMINUS OF THE 3800-MOLECULAR-WEIGHT ANTIGEN FROM STREPTOCOCCUS MUTANS
105 JAY A. HARON, CHERYL K. BOHART, LISA N. STAFFILENO, PHILIP VAN HOOK,
AND THOMAS LEHNER CONTENTS XIX CLONING AND EXPRESSION OF A GENE OF
COXIELLA BURNETII ENCODING A MAJOR ANTIGEN HOMOLOGOUS TO A PROTEIN IN
MYCOBACTERIUM AND ESCHERICHIA COLI 111 MICHAEL H. VODKIN, CHRISTOPHER R.
BOLT, AND JIM C. WILLIAMS PRESENTATION OF FOREIGN EPITOPES AT THE
SURFACE OF LIVE RECOMBINANT BACTERIA: IMMUNIZATION STUDIES 117 ALAIN
CHARBIT, ANNIE MOLLA, SYLVIE VAN DER WERF, ELIANE SOBCZAK, MARIE-LOUISE
MICHEL, MARC GIRARD, PIERRE TIOLLAIS, AND MAURICE HOFNUNG USE OF T-CELL
HYBRIDOMA PRODUCTS TO PREVENT BACTERIAL DISEASE 121 ROBERT FINBERG,
ABBEBE HAREGEWOIN, JEFFREY BERGELSON, JOSEPH CRABB, DENNIS KASPER, AND
ANDREW ONDERDONK SECTION IV VIROLOGY CHIMERIC PROTEINS BASED ON
HEPATITIS-B CORE ANTIGEN FORM HIGHLY IMMUNOGENIC PARTICLES 127 BERWYN E.
CLARKE, ANTHONY R. CARROLL, MICHAEL J. FRANCIS, GEOFFREY APPLEYARD,
ANDREW D. SYRED, PETER E. HIGHFIELD, DAVID J. ROWLANDS, FRED BROWN, AND
SUSAN E. NEWTON USE OF INFECTIOUS HEPATITIS-A VIRUS CDNA TO STUDY VIRAL
ATTENUATION 133 JEFFREY I. COHEN, BETSY ROSENBLUM, STEPHEN FEINSTONE,
JOHN R. TICEHURST, AND ROBERT H. PURCELL COMPARISON OF NUCLEOTIDE
SEQUENCES OF THE A/ANN ARBOR/6/60 LIVE ATTENUATED INFLUENZA VACCINE
DONOR STRAIN AND ITS WILD-TYPE PARENT 139 NANCY J. COX, FUMIO KITAME,
AND ALAN P. KENDAL IDENTIFICATION OF FOUR GENES THAT ATTENUATE INFLUENZA
A/ANN ARBOR/6/60 (H2N2) COLD-ADAPTED REASSORTANT VIRUSES 145 MARK H.
SNYDER, BRIAN R. MURPHY, ROBERT F. BETTS, MARY LOU CLEMENTS, STEVEN D.
SEARS, DIEDRE HERRINGTON, AND HUNEIN F. MAASSAB DEVELOPMENT OF A
ROTAVIRUS VACCINE BY A JENNERIAN AND A MODIFIED JENNERIAN APPROACH
151 ALBERT Z. KAPIKIAN, JORGE FLORES, KAREN MIDTHUN, YASUTAKA HOSHINO,
KIM Y. GREEN, MARIO GORZIGLIA, KOKI TANIGUCHI, KAZUO NISHIKAWA, ROBERT
M. CHANOCK, LOUIS POTASH, IRENE PEREZ-SCHAEL, RAPHAEL DOLIN, CYNTHIA
CHRISTY, MATHURAM SANTOSHAM, NEAL A. HALSEY, MARY LOU CLEMENTS, STEPHEN
D. SEARS, ROBERT E. BLACK, MYRON M. LEVINE, GENEVIEVE A. LOSONSKY,
MARGARET B. RENNELS, LEIF GOTHEFORS, GORAN WADELL, ROGER I. GLASS, TIMO
VESIKARI, EDWIN L. ANDERSON, ROBERT B. BELSHE, PETER F. WRIGHT AND SHOZO
URASAWA ANTIGENIC ANALYSIS OF THE DENGUE VIRUS ENVELOPE GLYCOPROTEIN
USING SYNTHETIC PEPTIDES 161 LEWIS J. MARKOFF, MICHAEL BRAY, CHING-JHU
LAI, ROBERT M. CHANOCK, KENNETH ECKELS, PETER SUMMERS, MARY KAY GENTRY,
RICHARD HOUGHTON, AND RICHARD A. LERNER SIMIAN MODELS FOR AIDS: SIV/SMM
AND HIV-2 INFECTION OF MACAQUES 167 PARTICIA N. FULTZ, WILLIAM SWITZER,
HAROLD M. MCCLURE, DANIEL ANDERSON, AND LUC MONTAGNIER XX CONTENTS
DEVELOPMENT OF LIVE VIRUS AND SUBUNIT VACCINES FOR PARAINFLUENZA TYPE-3
VIRUS , 171 KATHLEEN COELINGH, PETER COLLINS, BRIAN MURPHY, JAMES
BATTEY, AND ANNE-MARIE LEBACQ-VERHEYDEN ATTENUATION OF LIVE RECOMBINANT
VACCINIA VIRUS VECTORS BY EXPRESSION OF HUMAN LNTERLEUKIN-2 179 CHARLES
FLEXNER, AMBROS HUGIN, AND BERNARD MOSS IMMUNOGENICITY OF A RECOMBINANT
VARICELLA ZOSTER VIRUS IN THE COMMON MARMOSET 185 ROBERT S. LOWE, PAUL
MALCOLM KELLER, PHILIP J. PROVOST, FRANK S. BANKER, JANG HAN, EMILIO A.
EMINI, AND RONALD W. ELLIS PASSIVE IMMUNE SERUM INHIBITS ANTIBODY
RESPONSE TO RECOMBINANT VACCINIA VIRUS 189 MICHAEL P. JOHNSON, CATHERINE
A. MEITIN, BRADLEY S. BENDER, AND PARKER A. SMALL, JR. R7017 AND R7020
HERPES SIMPLEX VIRUS RECOMBINANT PROTOTYPE VACCINE STRAINS: ANIMAL
STUDIES 193 BERNARD MEIGNIER, RICHARD LONGNECKER, AND BERNARD ROIZMAN
POLIOVIRUS TYPE 1 /TYPE 3 ANTIGENIC HYBRID VIRUS CONSTRUCTED IN VITRO
ELICITS TYPES 1 AND 3 NEUTRALIZING ANTIBODIES IN RABBITS 197 MICHAEL G.
MURRAY, RICHARD J. KUHN, AND ECKARD WIMMER EVALUATION IN NONHUMAN
PRIMATES OF THE SAFETY, IMMUNOGENICITY, AND EFFICACY OF RECOMBINANT
VACCINIA VIRUSES EXPRESSING THE FOR G GLYCOPROTEIN OF RESPIRATORY
SYNCYTIAL VIRUS 205 ROBERT A. OLMSTED, ROBERT M.L. BULLER, BRIAN R.
MURPHY, JUDY A. BEELER, PETER L. COLLINS, AND WILLIAM T. LONDON
ENGINEERING VACCINIA VIRUS VECTORS THAT EXPRESS HYBRID PROTEINS
CONTAINING IMMUNOGENIC SEQUENCES ON THE CELL SURFACE 211 SATCHIDANANDAM
VIJAYA, NARAYANASWAMY ELANGO, AND BERNARD MOSS VIRUS EPITOPES THAT
INDUCE CYTOTOXIC T LYMPHOCYTES CAN BE RECOGNIZED AS SHORT PEPTIDES AND
ARE SELECTED BY CLASS I MHC MOLECULES 215 J. LINDSAY WHITTON, HANNA
LEWICKI, JOHN R. GEBHARD, ANTOINETTE TISHON, PETER J. SOUTHERN, AND
MICHAEL B.A. OLDSTONE MOLECULAR CHARACTERIZATION OF SABIN TYPE-3
POLIOVIRUS STRAINS: SEQUENCE CORRELATES TO NEUROVIRULENCE TEST RESULTS
223 CAROLYN WEEKS-LEVY, STEVEN J. MENTO, BARBARA MORGAN DETJEN, AND
FRANCIS R. CANO DESIGN OF SYNTHETIC PEPTIDES MIMICKING THE IMMUNOLOGIC
AND BIOLOGIC FUNCTIONS OF THE PRE-S1 SEQUENCE OF THE HEPATITIS-B VIRUS
ENVELOPE PROTEIN 229 A. ROBERT NEURATH, NATHAN STRICK, STEPHEN B.H.
KENT, KAREN PARKER, BELINDA SETO, AND MARC GIRARD TRYPSIN SENSITIVITY OF
EPITOPES WITHIN THE HEPATITIS-A VIRUS IMMUNODOMINANT NEUTRALIZATION SITE
235 JACK T. STAPLETON AND DAVID K. LANGE CONTENTS XXI ANTIGEN-PRESENTING
CELLS CONTROL T-CELL RESPONSIVENESS TO FRIEND MURINE LEUKEMIA VIRUS
ENVELOPE ANTIGEN 241 MASAAKI MIYAZAWA, JANE NISHIO, AND BRUCE CHESEBRO
LNTERLEUKIN-2 AS AN ADJUVANT TO VACCINATION 247 JACK H. NUNBERG, MICHAEL
V. DOYLE, ARTHUR D. NEWELL, GARY A. ANDERSON, AND CHARLES J. YORK
SECTION V AIDS MAPPING OF THE PRINCIPAL HUMAN IMMUNODEFICIENCY VIRUS
NEUTRALIZING EPITOPE 253 SCOFF D. PUTNEY, JAMES R. RUSCHE, KASHI
JAVAHERIAN, JOAN PETRO, DEBRA L. LYNN, THOMAS J. O KEEFFE, RAYMOND
GRIMAILA, CHARLENE MCDANAL, DANI P. BOLOGNESI, THOMAS J. MATTHEWS, SHUZO
MATSUSHITA, MARJORIE ROBERT-GUROFF, AND ROBERT C. GALLO DISTINGUISHING
FEATURES OF NEUROTROPIC HUMAN IMMUNODEFICIENCY VIRUSES 259 CECILIA
CHENG-MAYER, MASATOSHI TATENO, DEBORAH SETO, AND JAY A. LEVY FUNCTIONAL
ROLE OF CD8 + LYMPHOCYTES IN SIMIAN IMMUNODEFICIENCY VIRUS INFECTION OF
RHESUS MONKEYS 265 NORMAN L. LETVIN AND MARI KANNAGI SITE-DIRECTED ELISA
IDENTIFIES A HIGHLY ANTIGENIC REGION OF THE SIMIAN IMMUNODEFICIENCY
VIRUS TRANSMEMBRANE GLYCOPROTEIN 271 PHILIP R. JOHNSON, ROBERT H.
PURCELL, ROBERT M. CHANOCK, D. ELLIOT PARKS, ERLING NORRBY, AND RICHARD
A. LERNER PREPARATION AND EVALUATION OF A HUMAN IMMUNODEFICIENCY VIRUS
GP120 PROTOTYPE VACCINE 277 LARRY O. ARTHUR, STEPHEN W. PYLE, JULIAN W.
BESS, JR., RAYMOND V. GILDEN, PETER L. NARA, W. GERARD ROBEY, PETER J.
FISCHINGER, AND JOHN C. KELLIHER TRANSCRIPTIONAL REGULATION OF HUMAN
IMMUNODEFICIENCY VIRUS TYPE 1 283 B. MATIJA PETERLIN, ANDREW F. CAIMAN,
SHAW-YI KAO, MARK J. SELBY, SANDRA E. TONG-STARKSEN, AND PAUL A. LUCIW
HUMAN IMMUNODEFICIENCY VIRUS SPECIFIC T-CELL IMMUNITY IN SEROPOSITIVE,
ASYMPTOMATIC INDIVIDUALS 291 GERALD LINETTE, PHILLIP PIERCE, DENNIS
WONG, KENNETH WAGNER, EDITH SMITH, THOMAS FOLKS, AND ROBERT HARTZMAN
ENVELOPE GENE VARIATION IN EQUINE INFECTIOUS ANEMIA VIRUS: IMPLICATIONS
FOR VACCINE DEVELOPMENT 297 SUSAN L. PAYNE, JUDITH M. BALL, CHARLES J.
ISSEL, RONALD C. MONTELARO, AND KEITH RUSHLOW FUNCTIONAL ANALYSIS OF THE
TAT AND TRS GENES OF HUMAN IMMUNODEFICIENCY VIRUS BY SITE-DIRECTED
MUTAGENESIS 303 M. REZA SADAIE, STEVEN F. JOSEPHS, JAY RAPPAPORT,
RUDOLPH WILLIS, ROBERT C. GALLO, FLOSSIE WONG-STAAL, AND THOMAS BENTER
XXII CONTENTS FUNCTIONAL ANALOGIES WITH CELLULAR ONCOGENE PRODUCTS IMPLY
A ROLE FOR HIV-F (3 ORF) IN CELL REGULATION 311 BRUNO GUY, MARIE PAULE
KIENY, JEAN-PIERRE LECOCQ, YVES RIVIERE, LUC MONTAGNIER, AND MARC GIRARD
PHYLOGENETIC ANALYSIS OF HIV-1 AND HIV-2 317 TEMPLE F. SMITH, MIRA
MARCUS, AND GERALD MYERS DISCORDANT VIRUS NEUTRALIZATION AND ANTI-HIV
ADCC ACTIVITY IN HIV- SEROPOSITIVE PATIENT SERA 323 H. KIM LYERLY, JEAN
E. PRATZ, DOUGLAS S. TYLER, THOMAS J. MATTHEWS, ALPHONSE J. LANGLOIS,
DANI P. BOLOGNESI, AND KENT J. WEINHOLD SYNTHETIC PEPTIDE REAGENTS
SEROLOGICALLY DISTINGUISH AMONG INFECTIONS CAUSED BY HIV-1 STRAINS AND
BETWEEN HIV-1 AND HIV-2 INFECTIONS 327 JOHN W. GNANN, JR., JAY A.
NELSON, MICHAEL B.A. OLDSTONE, AND JOSEPH B. MCCORMICK TYPE-SPECIFIC
SITE-DIRECTED HUMAN IMMUNODEFICIENCY VIRUS SEROLOGY 335 ERLING NORRBY,
FRANCESCA CHIODI, GUNNEL BIBERFELD, MAURICE A. MUFSON, ELLIOT PARKS, AND
RICHARD A. LERNER PERSISTENT IN VITRO INFECTION OF MACROPHAGES BY THE
HUMAN IMMUNODEFICIENCY VIRUS 341 HOWARD E. GENDELMAN, MALCOLM A. MARTIN,
JAN ORENSTEIN, TERRY PHIPPS, AND MONTE S. MELTZER RECOMBINANT ENV AND
GAG POLYPETIDES IN CHARACTERIZING HIV-1- NEUTRALIZING ANTIBODIES 347
KATHELYN S. STEIMER, GARY A. VAN NEST, NANCY L. HAIGWOOD, ELIZABETH M.
TILLSON, CARLOS GEORGE-NASCIMENTO, PHILIP J. BARR, AND DINO DANA
IDENTIFICATION OF TWO T-CELL SPECIFIC EPITOPES IN THE CONSERVED REGIONS
OF HUMAN IMMUNODEFICIENCY VIRUS 357 KAI J.E. KROHN, PAOLO LUSSO, ROBERT
C. GALLO, ANNAMARI RANKI, LARRY , 0. ARTHUR, BERNARD MOSS, AND SCOTT
PUTNEY SPECIFIC T-CELL RESPONSE TOWARD VIRAL ANTIGENS IN GIBBON APES
{HYLOBATES LAR) INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS 361 PAOLO
LUSSO, ANNAMARI RANKI, ROBERT C. GALLO, KAI J.E. KROHN, PHILLIP D.
MARKHAM, AND STEPHEN S. KUEBERUWA IDENTIFICATION OF HUMAN
IMMUNODEFICIENCY VIRUS ANTIGENIC SUBTYPES WITH RELEVANCE TO AIDS
VACCINES: A PROTOTYPE STUDY 365 JACQUES HOMSY, CECILIA CHENG-MAYER,
MASATOSHI TATENO, AND JAY A. LEVY ASSOCIATION BETWEEN ANTIBODY TO
ENVELOPE GLYCOPROTEIN GP120 AND THE OUTCOME OF HUMAN IMMUNODEFICIENCY
VIRUS INFECTION 373 TUN-HOU LEE, MIN-JI CHOU, JUI-HAN HUANG, XIAO-FANG
YU, JONATHAN ALLEN, MARY F. MCLANE, RICHARD MARLINK, MAX ESSEX, ROBERT
R. REDFIELD, DONALD S. BURKE, CHUNG-CHENG HSIEH, AND ALFRED SAAH SUMMARY
379 R.A. LERNER POSTERS, 381 AUTHOR INDEX, 389 SUBJECT INDEX, 393
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV000826658 |
| ctrlnum | (OCoLC)230931936 (DE-599)BVBBV000826658 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01748nam a2200433 cb4500</leader><controlfield tag="001">BV000826658</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">881024s1988 a||| |||| 10||| und d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">087969310X</subfield><subfield code="9">0-87969-310-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)230931936</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000826658</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">und</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New chemical and genetic approaches to vaccination</subfield><subfield code="b">prevention of AIDS and other viral, bacterial, and parasitic diseases</subfield><subfield code="c">ed. by Harold Ginsberg ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cold Spring Harbor</subfield><subfield code="b">Cold Spring Harbor Laboratory</subfield><subfield code="c">1988</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXII, 396 S.</subfield><subfield code="b">Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Vaccines</subfield><subfield code="v">1988</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Aids</subfield><subfield code="0">(DE-588)4112470-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfung</subfield><subfield code="0">(DE-588)4026656-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Virusimpfstoff</subfield><subfield code="0">(DE-588)4257636-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1987</subfield><subfield code="z">Cold Spring Harbor NY</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Impfung</subfield><subfield code="0">(DE-588)4026656-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Virusimpfstoff</subfield><subfield code="0">(DE-588)4257636-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Aids</subfield><subfield code="0">(DE-588)4112470-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ginsberg, Harold</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Vaccines</subfield><subfield code="v">1988</subfield><subfield code="w">(DE-604)BV000345041</subfield><subfield code="9">1988</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000518934&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000518934</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1987 Cold Spring Harbor NY gnd-content |
| genre_facet | Konferenzschrift 1987 Cold Spring Harbor NY |
| id | DE-604.BV000826658 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T15:20:06Z |
| institution | BVB |
| isbn | 087969310X |
| language | Undetermined |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000518934 |
| oclc_num | 230931936 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | XXII, 396 S. Ill. |
| publishDate | 1988 |
| publishDateSearch | 1988 |
| publishDateSort | 1988 |
| publisher | Cold Spring Harbor Laboratory |
| record_format | marc |
| series | Vaccines |
| series2 | Vaccines |
| spelling | New chemical and genetic approaches to vaccination prevention of AIDS and other viral, bacterial, and parasitic diseases ed. by Harold Ginsberg ... Cold Spring Harbor Cold Spring Harbor Laboratory 1988 XXII, 396 S. Ill. txt rdacontent n rdamedia nc rdacarrier Vaccines 1988 Aids (DE-588)4112470-4 gnd rswk-swf Impfung (DE-588)4026656-4 gnd rswk-swf Impfstoff (DE-588)4026655-2 gnd rswk-swf Virusimpfstoff (DE-588)4257636-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1987 Cold Spring Harbor NY gnd-content Impfstoff (DE-588)4026655-2 s DE-604 Impfung (DE-588)4026656-4 s Virusimpfstoff (DE-588)4257636-2 s Aids (DE-588)4112470-4 s Ginsberg, Harold Sonstige oth Vaccines 1988 (DE-604)BV000345041 1988 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000518934&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | New chemical and genetic approaches to vaccination prevention of AIDS and other viral, bacterial, and parasitic diseases Vaccines Aids (DE-588)4112470-4 gnd Impfung (DE-588)4026656-4 gnd Impfstoff (DE-588)4026655-2 gnd Virusimpfstoff (DE-588)4257636-2 gnd |
| subject_GND | (DE-588)4112470-4 (DE-588)4026656-4 (DE-588)4026655-2 (DE-588)4257636-2 (DE-588)1071861417 |
| title | New chemical and genetic approaches to vaccination prevention of AIDS and other viral, bacterial, and parasitic diseases |
| title_auth | New chemical and genetic approaches to vaccination prevention of AIDS and other viral, bacterial, and parasitic diseases |
| title_exact_search | New chemical and genetic approaches to vaccination prevention of AIDS and other viral, bacterial, and parasitic diseases |
| title_full | New chemical and genetic approaches to vaccination prevention of AIDS and other viral, bacterial, and parasitic diseases ed. by Harold Ginsberg ... |
| title_fullStr | New chemical and genetic approaches to vaccination prevention of AIDS and other viral, bacterial, and parasitic diseases ed. by Harold Ginsberg ... |
| title_full_unstemmed | New chemical and genetic approaches to vaccination prevention of AIDS and other viral, bacterial, and parasitic diseases ed. by Harold Ginsberg ... |
| title_short | New chemical and genetic approaches to vaccination |
| title_sort | new chemical and genetic approaches to vaccination prevention of aids and other viral bacterial and parasitic diseases |
| title_sub | prevention of AIDS and other viral, bacterial, and parasitic diseases |
| topic | Aids (DE-588)4112470-4 gnd Impfung (DE-588)4026656-4 gnd Impfstoff (DE-588)4026655-2 gnd Virusimpfstoff (DE-588)4257636-2 gnd |
| topic_facet | Aids Impfung Impfstoff Virusimpfstoff Konferenzschrift 1987 Cold Spring Harbor NY |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000518934&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000345041 |
| work_keys_str_mv | AT ginsbergharold newchemicalandgeneticapproachestovaccinationpreventionofaidsandotherviralbacterialandparasiticdiseases |